Bank of America
CAMP icon

Bank of America’s CAMP4 Therapeutics CAMP Stock Holding History

Bank of America’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.7K Sell
17,773
-13,423
-43% -$57.9K ﹤0.01% 5552
2026
Q1 		$138K Buy
31,196
+31,174
+141,700% +$148K ﹤0.01% 5464
2025
Q4 		$135 Sell
22
-261
-92% -$1.11K ﹤0.01% 6769
2025
Q3 		$849 Sell
283
-369
-57% -$683 ﹤0.01% 7513
2025
Q2 		$946 Sell
652
-2,612
-80% -$5.2K ﹤0.01% 7543
2025
Q1 		$13.1K Sell
3,264
-13,195
-80% -$63.8K ﹤0.01% 7065
2024
Q4 		$85.9K Buy
+16,459
New +$135K ﹤0.01% 6457

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America's CAMP Position: Q2 2026 in Review

Bank of America reduced its CAMP4 Therapeutics (CAMP) stake by 43% in Q2 2026, selling an estimated $57.9K and leaving 17,773 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5552.

Bank of America first reported a position in CAMP in Q4 2024 and has held it in 7 quarters since. The position peaked at $138K in Q1 2026. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Bank of America held 17,773 shares of CAMP4 Therapeutics worth $77.7K as of Q2 2026.
  • Bank of America sold 13,423 CAMP4 Therapeutics shares in Q2 2026, an estimated $57.9K.
  • CAMP4 Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5552 holding.
  • Bank of America first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Bank of America's CAMP4 Therapeutics position peaked at $138K in Q1 2026.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.